Hummingbird Bioscience

Industry

  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Technologies
      • Bioinformatics
    • Pharmacogenetics-Pharmacogenomics
See more in Biomedtracker

Latest on Hummingbird Bioscience

Scrip

Taiho Expands Cancer Pipeline With ADCs In $400m Araris Buy

 
• By Mandy Jackson

Taiho Pharmaceuticals said on 17 March that it will spend $400m up front and up to $740m in milestone payments to expand its cancer drug development pipeline through the acquisition of antibody-drug c

Scrip

Callio Therapeutics Aims To Overcome Enhertu Resistance With Multi-Payload ADCs

 
• By Andrew McConaghie

A new biotech company, Callio Therapeutics, has been launched with the goal of developing multi-payload antibody-drug conjugates (ADCs), an approach it and several other companies are exploring to boo

Scrip

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January

Scrip

Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A